Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · IEX Real-Time Price · USD
3.570
-0.620 (-14.80%)
At close: Jul 2, 2024, 4:00 PM
3.730
+0.160 (4.48%)
After-hours: Jul 2, 2024, 7:52 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $253.52 million as of July 2, 2024. Its market cap has decreased by -85.30% in one year.
Market Cap
253.52M
Enterprise Value
-195.53M
1-Year Change
-85.30%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $762.70M to $253.52M, a decrease of -66.76%. That is a compound annual growth rate of -22.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 297.50M | -72.25% |
| Dec 29, 2023 | 1.07B | -6.73% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 176.58% |
| Apr 3, 2020 | 762.70M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 312.08M |
| Alto Neuroscience | 306.48M |
| SOPHiA GENETICS | 303.34M |
| Spok Holdings | 302.07M |
| DocGo | 297.59M |
| Procaps Group | 294.47M |
| Poseida Therapeutics | 291.84M |
| XOMA Corporation | 289.80M |